Gemcitabine and oxaliplatin combination: A multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.

被引：0
|
作者：
Font, A
Esteban, E
Carles, J
Climent, MA
Gonzalez-Larriba, JL
Berrocal, A
Bellmunt, J
Garcia-Ribas, I
Marfa, X
Fabregat, X
机构：
[1] Hosp Germans Trias & Pujol, Badalona, Spain
[2] Hosp Gen Asturias, E-33006 Oviedo, Spain
[3] Hosp Mar, Barcelona, Spain
[4] Inst Valenciano Oncol, Valencia, Spain
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Gen Hosp, Valencia, Spain
[7] Hosp Gen Valle Hebron, Barcelona, Spain
[8] Eli Lilly & Co, Alcobendas, Spain
[9] Sanofi Sinthelabo, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4544
引用
收藏
页码：392S / 392S
页数：1
相关论文
共 50 条
  • [41] Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
    Lee, Kyung Hee
    Kim, Min Kyoung
    Kim, Yeol Hong
    Ryoo, Baek Yeol
    Lim, Ho Yeong
    Song, Hong Suk
    Kim, Hoon Kyo
    Lee, Myung Ah
    Im, Seock Ah
    Chang, Heung Moon
    Cho, Jae Yong
    Zang, Dae Young
    Kim, Bong Seog
    Kim, Jun Suk
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 317 - 325
  • [42] Gemcitabine and oxaliplatin combination as the first-line treatment in advanced pancreatic cancer: A multicenter phase II study
    Lee, K.
    Kim, M.
    Kim, Y.
    Ryoo, B.
    Lim, H.
    Song, H.
    Kim, H.
    Lee, M.
    Im, S.
    Chang, H.
    Cho, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer
    Balar, Arjun V.
    Apolo, Andrea B.
    Ostrovnaya, Irina
    Mironov, Svetlana
    Iasonos, Alexia
    Trout, Alisa
    Regazzi, Ashley M.
    Garcia-Grossman, Ilana R.
    Gallagher, David J.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) : 724 - 730
  • [44] Phase I/II trial of pembrolizumab in combination with binimetinib in unresectable locally advanced or metastatic triple negative breast cancer.
    Chumsri, Saranya
    Polley, Mei-Yin
    Anderson, Sarah L.
    O'Sullivan, Ciara Catherine Maria
    Colon-Otero, Gerardo
    Knutson, Keith L.
    Thompson, E. Aubrey
    Moreno-Aspitia, Alvaro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [45] Preliminary results of phase II trial with combination of gemcitabine and oxaliplatin in elderly patients with advanced NSCLC.
    Buosi, R
    Poletti, S
    Cantele, V
    Piazza, S
    Torazzo, R
    Negru, E
    Vandone, A
    Alabiso, O
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 703S - 703S
  • [46] A Multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer
    Ignatiadis, Michail
    Polyzos, Aris
    Stathopoulos, George P.
    Tselepatiotis, Evangelos
    Christophylakis, Charalambos
    Kalbakis, Kostas
    Vamvakas, Lambros
    Kotsakis, Athanasios
    Potamianou, Anna
    Georgoulias, Vassilis
    [J]. ONCOLOGY, 2006, 71 (3-4) : 159 - 163
  • [47] A randomized phase III study of irinotecan/gemcitabine combination versus gemcitabine in patients with advanced/metastatic pancreatic cancer.
    Stathopoulos, GP
    Aravantinos, G
    Syrigos, K
    Kalbakis, K
    Karvounis, N
    Papakotoulas, P
    Boukovinas, J
    Potamianou, A
    Polyzos, A
    Christophilakis, CH
    Georgoulias, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [48] Phase I/II trial of carbon-ion radiotherapy with concurrent gemcitabine for patients with locally advanced pancreatic cancer.
    Shinoto, Makoto
    Yamada, Shigeru
    Yasuda, Shigeo
    Imada, Hiroshi
    Shioyama, Yoshiyuki
    Honda, Hiroshi
    Kamada, Tadashi
    Tsujii, Hirohiko
    Saisho, Hiromitsu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer.
    Kortmansky, JS
    O'Reilly, EM
    Minsky, BD
    Puleio, SA
    Winkelmann, J
    Kelsen, DP
    Schwartz, GK
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 334S - 334S
  • [50] Neoadjuvant gemcitabine, epirubicin, and docetaxel (GET). Preliminary results from a multicenter phase II trial in inflammatory and locally advanced breast cancer.
    Yardley, DA
    Whitworth, P
    Greco, FA
    Burris, HA
    White, M
    Thomas, M
    Dunbar, L
    Yost, K
    Hainsworth, JD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S54 - S54
12345